» Articles » PMID: 30327616

Cardiovascular Autonomic Profile in Women With Premenstrual Syndrome

Overview
Journal Front Physiol
Date 2018 Oct 18
PMID 30327616
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The premenstrual syndrome (PMS) is a constellation of somatic and psychogenic symptoms that appear during late luteal (LL) phase of the menstrual cycle. Since many symptoms could be related to the autonomic nervous system, we hypothesized that the sympathetic nervous system is perturbed in PMS. The cardiovascular autonomic profile of nine women with PMS (30.4 ± 2.5 years) were compared to that of nine healthy controls (30 ± 2.5 years) during their early follicular (EF) and LL phases of the menstrual cycle. Plasma norepinephrine (NE) concentrations, power spectral analysis of heart rate and systolic blood pressure (BP), and baroreflex sensitivity (BRS) were assessed during recumbency and a head-up tilt (HUT). Cardiovascular responsiveness to α1- and β-adrenoreceptor agonists (phenylephrine and isoproterenol, respectively) were also assessed. In the LL phase, the plasma NE concentrations in women with PMS during recumbency and a HUT were lower than those in women without PMS [180 ± 30 vs. 320 ± 50 pg/ml; = 0.04 (recumbent), and 480 ± 70 vs. 940 ± 180 pg/ml: = 0.02 (HUT)]. In the LL phase, the dose of phenylephrine required to increase systolic BP by 15 mmHg in women with PMS was significantly greater than that in women without PMS (202 ± 30 μg vs. 138 ± 20 μg; = 0.02). Sympathetic and vagal cardiac control indices were comparable in the two groups in the menstrual phases. In women with PMS, the value of LF in the LL phase was lower than that in the EF phase (0.98 ± 0.2 vs. 1.77 ± 0.4 mmHg, = 0.04). The increase in LF in women with PMS in the LL phase during HUT was greater than that in the controls, 5.2 ± 0.9 vs. 3.1 ± 0.5 mmHg, = 0.045, and this increase was associated with a significant decrease in BRS. In women with PMS without psychogenic symptoms, the sympathetic control of their circulation is not dominant during the LL phase of their menstrual cycle.

Citing Articles

Effect of pranayama on sympatho-vagal imbalance and cognitive deficit in premenstrual syndrome.

Feula A, Yerrabelli D, Pal G J Family Med Prim Care. 2024; 13(1):259-264.

PMID: 38482308 PMC: 10931898. DOI: 10.4103/jfmpc.jfmpc_1104_23.


Females with Diabetes Mellitus Increased the Incidence of Premenstrual Syndrome.

Huang Y, Chien W, Cheng C, Chang Y, Chung C, Cheng C Life (Basel). 2022; 12(6).

PMID: 35743808 PMC: 9224876. DOI: 10.3390/life12060777.


The effect of age on the heart rate variability of healthy subjects.

Garavaglia L, Gulich D, Defeo M, Thomas Mailland J, Irurzun I PLoS One. 2021; 16(10):e0255894.

PMID: 34624048 PMC: 8500436. DOI: 10.1371/journal.pone.0255894.


Increased Incidence of Premenstrual Syndrome in Females with Palmar Hyperhidrosis.

Cheng C, Liang Y, Chang Y, Cheng C, Chung C, Chien W Int J Environ Res Public Health. 2021; 18(9).

PMID: 33925001 PMC: 8124344. DOI: 10.3390/ijerph18094697.

References
1.
Jacob G, Shannon J, Costa F, Furlan R, Biaggioni I, Robertson R . Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation. 1999; 99(13):1706-12. DOI: 10.1161/01.cir.99.13.1706. View

2.
Bertinieri G, Di Rienzo M, CAVALLAZZI A, Ferrari A, Pedotti A, Mancia G . A new approach to analysis of the arterial baroreflex. J Hypertens Suppl. 1985; 3(3):S79-81. View

3.
Landen M, Wennerblom B, Tygesen H, Modigh K, Sorvik K, Ysander C . Heart rate variability in premenstrual dysphoric disorder. Psychoneuroendocrinology. 2004; 29(6):733-40. DOI: 10.1016/S0306-4530(03)00117-3. View

4.
Wheeldon N, Newnham D, Coutie W, Peters J, McDevitt D, Lipworth B . Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol. 1994; 37(6):583-8. PMC: 1364819. DOI: 10.1111/j.1365-2125.1994.tb04308.x. View

5.
Pagani M, Malliani A . Interpreting oscillations of muscle sympathetic nerve activity and heart rate variability. J Hypertens. 2001; 18(12):1709-19. DOI: 10.1097/00004872-200018120-00002. View